KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) EPS (Basic) (2016 - 2025)

Amgen has reported EPS (Basic) over the past 17 years, most recently at $2.47 for Q4 2025.

  • Quarterly results put EPS (Basic) at $2.47 for Q4 2025, up 111.11% from a year ago — trailing twelve months through Dec 2025 was $14.33 (up 88.06% YoY), and the annual figure for FY2025 was $14.33, up 88.06%.
  • EPS (Basic) for Q4 2025 was $2.47 at Amgen, down from $5.98 in the prior quarter.
  • Over the last five years, EPS (Basic) for AMGN hit a ceiling of $5.98 in Q3 2025 and a floor of -$0.21 in Q1 2024.
  • Median EPS (Basic) over the past 5 years was $2.77 (2021), compared with a mean of $2.85.
  • Biggest five-year swings in EPS (Basic): tumbled 103.95% in 2024 and later surged 1633.33% in 2025.
  • Amgen's EPS (Basic) stood at $3.36 in 2021, then decreased by 10.12% to $3.02 in 2022, then crashed by 52.32% to $1.44 in 2023, then fell by 18.75% to $1.17 in 2024, then skyrocketed by 111.11% to $2.47 in 2025.
  • The last three reported values for EPS (Basic) were $2.47 (Q4 2025), $5.98 (Q3 2025), and $2.66 (Q2 2025) per Business Quant data.